- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/203 - Acides rétinoïques
Détention brevets de la classe A61K 31/203
Brevets de cette classe: 684
Historique des publications depuis 10 ans
|
53
|
56
|
50
|
68
|
60
|
52
|
52
|
42
|
45
|
33
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Galderma Research & Development | 397 |
26 |
| Sol-gel Technologies Ltd. | 127 |
14 |
| Beth Israel Deaconess Medical Center, Inc. | 859 |
13 |
| Sun Pharmaceutical Industries Limited | 749 |
13 |
| Rush University Medical Center | 310 |
11 |
| Mayne Pharma LLC | 53 |
10 |
| Textile-Based Delivery, Inc. | 24 |
9 |
| The Regents of the University of California | 20137 |
8 |
| Galderma S.A. | 138 |
8 |
| Indiana University Research and Technology Corporation | 801 |
8 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3186 |
8 |
| Bausch Health Ireland Limited | 795 |
8 |
| Johnson & Johnson Vision Care, Inc. | 1181 |
7 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3368 |
7 |
| Skintech Life Science Limited | 21 |
7 |
| Curology, Inc. | 72 |
7 |
| The Johns Hopkins University | 5723 |
6 |
| Monash University | 715 |
6 |
| The Trustees of Columbia University in the City of New York | 3592 |
5 |
| Cornell University | 3342 |
5 |
| Autres propriétaires | 498 |